These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 17507152)
1. The use of local anesthesia with N-DO injector (Physion) for transurethral resection (TUR) of bladder tumors and bladder mapping: preliminary results and cost-effectiveness analysis. Brausi MA; Verrini G; De Luca G; Viola M; Simonini GL; Peracchia G; Gavioli M Eur Urol; 2007 Nov; 52(5):1407-11. PubMed ID: 17507152 [TBL] [Abstract][Full Text] [Related]
2. Editorial comment on: The use of local anesthesia with N-DO Injector (Physion) for transurethral resection (TUR) of bladder tumors and bladder mapping: preliminary results and cost-effectiveness analysis. Oosterlinck W Eur Urol; 2007 Nov; 52(5):1411-2. PubMed ID: 17507153 [No Abstract] [Full Text] [Related]
3. Editorial comment on: The use of local anesthesia with N-DO injector (physion) for transurethral resection (TUR) of bladder tumors and bladder mapping: preliminary results and cost-effectiveness analysis. Jakse G Eur Urol; 2007 Nov; 52(5):1412-3. PubMed ID: 17507154 [No Abstract] [Full Text] [Related]
4. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529 [TBL] [Abstract][Full Text] [Related]
5. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases. Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290 [TBL] [Abstract][Full Text] [Related]
6. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. Daniltchenko DI; Riedl CR; Sachs MD; Koenig F; Daha KL; Pflueger H; Loening SA; Schnorr D J Urol; 2005 Dec; 174(6):2129-33, discussion 2133. PubMed ID: 16280742 [TBL] [Abstract][Full Text] [Related]
7. Transurethral partial cystectomy with continuous wave laser for bladder carcinoma. Yang Y; Wei ZT; Zhang X; Hong BF; Guo G J Urol; 2009 Jul; 182(1):66-9. PubMed ID: 19450852 [TBL] [Abstract][Full Text] [Related]
8. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204 [TBL] [Abstract][Full Text] [Related]
9. Watchful waiting policy in recurrent Ta G1 bladder tumors. Gofrit ON; Pode D; Lazar A; Katz R; Shapiro A Eur Urol; 2006 Feb; 49(2):303-6; discussion 306-7. PubMed ID: 16413659 [TBL] [Abstract][Full Text] [Related]
10. A re-staging transurethral resection predicts early progression of superficial bladder cancer. Herr HW; Donat SM BJU Int; 2006 Jun; 97(6):1194-8. PubMed ID: 16566813 [TBL] [Abstract][Full Text] [Related]
11. The actual incidence of bladder perforation following transurethral bladder surgery. Balbay MD; Cimentepe E; Unsal A; Bayrak O; Koç A; Akbulut Z J Urol; 2005 Dec; 174(6):2260-2, discussion 2262-3. PubMed ID: 16280794 [TBL] [Abstract][Full Text] [Related]
12. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer? Divrik T; Yildirim U; Eroğlu AS; Zorlu F; Ozen H J Urol; 2006 Apr; 175(4):1258-61. PubMed ID: 16515974 [TBL] [Abstract][Full Text] [Related]
13. One immediate postoperative instillation of chemotherapy in low risk Ta, T1 bladder cancer patients. Is it always safe? Oddens JR; van der Meijden AP; Sylvester R Eur Urol; 2004 Sep; 46(3):336-8. PubMed ID: 15306104 [TBL] [Abstract][Full Text] [Related]
14. [Fluorescent cystoscopy and transurethral electroresection in diagnosis and treatment of patients with invasive cancer of the urinary bladder]. Komiakov BK; Gorelov SI; Novikov AI; Gorelov AI; Novikov PB; Strokova LA; Al-Atar T Urologiia; 2004; (6):37-40. PubMed ID: 15719729 [TBL] [Abstract][Full Text] [Related]
15. The value of a second transurethral resection for T1 bladder cancer. Schwaibold HE; Sivalingam S; May F; Hartung R BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814 [TBL] [Abstract][Full Text] [Related]
16. Endoscopic therapy of superficial bladder cancer in high-risk patients: Holmium laser versus transurethral resection. Muraro GB; Grifoni R; Spazzafumo L Surg Technol Int; 2005; 14():222-6. PubMed ID: 16525976 [TBL] [Abstract][Full Text] [Related]
17. The cost of bladder tumour treatment and follow-up. Hedelin H; Holmäng S; Wiman L Scand J Urol Nephrol; 2002; 36(5):344-7. PubMed ID: 12487738 [TBL] [Abstract][Full Text] [Related]
18. Holmium:YAG laser vaporization of recurrent papillary tumours of the bladder under local anaesthesia. Jønler M; Lund L; Bisballe S BJU Int; 2004 Aug; 94(3):322-5. PubMed ID: 15291860 [TBL] [Abstract][Full Text] [Related]
19. Holmium laser treatment for low grade, low stage, noninvasive bladder cancer with local anesthesia and early instillation of mitomycin C. Soler-Martínez J; Vozmediano-Chicharro R; Morales-Jiménez P; Hernández-Alcaraz D; Vivas-Vargas E; Santos García-Vaquero I; Baena-González V J Urol; 2007 Dec; 178(6):2337-9. PubMed ID: 17936805 [TBL] [Abstract][Full Text] [Related]
20. [Non-epithelial tissue tumors of the urinary bladder]. Xu AX; Wang XX; Hong BF; Ye LY; Zhang L Zhonghua Wai Ke Za Zhi; 2003 Jul; 41(7):530-3. PubMed ID: 12921662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]